These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18813780)

  • 1. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
    Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
    Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
    Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation.
    Pucci B; Bellincampi L; Tafani M; Masciullo V; Melino G; Giordano A
    Exp Cell Res; 1999 Oct; 252(1):134-43. PubMed ID: 10502406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of G2/M arrest, endoreduplication, and apoptosis by actin depolymerization agent pextenotoxin-2 in human leukemia cells, involving activation of ERK and JNK.
    Moon DO; Kim MO; Kang SH; Lee KJ; Heo MS; Choi KS; Choi YH; Kim GY
    Biochem Pharmacol; 2008 Aug; 76(3):312-21. PubMed ID: 18571148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis.
    Vikhanskaya F; Vignati S; Beccaglia P; Ottoboni C; Russo P; D'Incalci M; Broggini M
    Exp Cell Res; 1998 May; 241(1):96-101. PubMed ID: 9633517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
    Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
    Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
    Chun E; Lee KY
    Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt.
    D'Anneo A; Augello G; Santulli A; Giuliano M; di Fiore R; Messina C; Tesoriere G; Vento R
    J Cell Physiol; 2010 Feb; 222(2):433-43. PubMed ID: 19918798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent antagonistic interactions between paclitaxel and gamma-radiation in combination therapy.
    Sui M; Dziadyk JM; Zhu X; Fan W
    Clin Cancer Res; 2004 Jul; 10(14):4848-57. PubMed ID: 15269161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
    Ling YH; Yang Y; Tornos C; Singh B; Perez-Soler R
    Cancer Res; 1998 Aug; 58(16):3633-40. PubMed ID: 9721872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs.
    Blagosklonny MV
    Oncogene; 2002 Sep; 21(41):6249-54. PubMed ID: 12214265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    Choi EJ; Kim GH
    J Nutr Biochem; 2009 Apr; 20(4):285-90. PubMed ID: 18656338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
    Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
    Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.
    Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T
    Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells.
    Héliez C; Baricault L; Barboule N; Valette A
    Oncogene; 2003 May; 22(21):3260-8. PubMed ID: 12761496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer.
    Giannakakou P; Poy G; Zhan Z; Knutsen T; Blagosklonny MV; Fojo T
    Oncogene; 2000 Jun; 19(27):3078-85. PubMed ID: 10871860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.